Cargando…
Novel Nitrile Peptidomimetics for Treating COVID-19
COVID-19 is a highly infectious disease caused by the viral pathogen SARS-CoV-2, causing an estimated 5.4 million fatalities globally in 2 years since its emergence in December 2019. On December 22, 2021, the U.S. FDA granted Emergency Use Authorization for the oral viral main protease inhibitor, Ni...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2022
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848505/ https://www.ncbi.nlm.nih.gov/pubmed/35291756 http://dx.doi.org/10.1021/acsmedchemlett.2c00030 |